NVCT
NVCT
NASDAQ · Biotechnology

Nuvectis Pharma Inc

$7.82
+0.09 (+1.16%)
As of Apr 1, 2:30 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +250.4% upside
Low Target $23.46
Average Target $27.40
High Target $40.51
Current Price $7.82
Current
$7.82
Target
$27.40
$23.46 $27.40 avg $40.51
Scenario Analysis
Bear Case
$23.46
200.0%
Low target
Base Case
$27.40
+250.4%
Avg target
Bull Case
$40.51
+418.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$11.52
-32.1% from high
52-Week Low
$5.55
+40.9% from low
Target vs 52W High
$27.40
+137.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%